AgomAb Therapeutics NV (AGMB)

NASDAQ: AGMB · Real-Time Price · USD

16.21

+0.19 (1.19%)

Mar 2, 2026, 4:00 PM EST - Market closed

AgomAb Therapeutics NV Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2019	FY 2018
Period Ending	Mar '26 Mar 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Market Capitalization	790	-	-	-	-	-
Enterprise Value	640	-	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.00	-	1.50
Net Debt / Equity Ratio	-0.87	-0.90	-0.80	-1.02	-1.11	-0.94
Net Debt / EBITDA Ratio	2.36	3.54	3.89	2.99	-	-
Net Debt / FCF Ratio	2.50	3.58	4.91	3.57	-	-
Quick Ratio	13.63	19.02	12.80	2.39	-	1.67
Current Ratio	13.99	19.05	12.81	2.39	-	1.67
Return on Equity (ROE)	-	-27.26%	-10.46%	-	-90.33%	-1901.98%
Return on Assets (ROA)	-	-15.90%	-14.32%	-	-49.38%	-139.78%
Return on Capital Employed (ROCE)	-34.90%	-24.30%	-19.40%	-31.80%	-41.30%	-295.40%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q